Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Matthew Haupt from Wilson Asset Management and Tim Johnston from Tyndall Asset Management discuss rate cut winners and losers ...

Noise level: Our pick for the best quiet CPAP machine is the Luna G3, but you'll want to make sure that whichever model you ...

EPS of $2.37 on $1.29 billion in sales, citing strong global demand for sleep devices, plus a boost from tariff exemptions.

A major Australian company has managed to secure a tariff exemption from the Trump Administration as the world waits to see ...

Resmed has named Salli Schwartz as chief investor relations officer, where she will lead the company’s global investor relations function and report to Mick Farrell, chairman of the board ...

Resmed reported third quarter 2025 revenues of $1.3 billion, an increase of 8% over the same quarter the prior year.

Mizuho lowered the firm’s price target on ResMed (RMD) to $250 from $265 and keeps an Outperform rating on the shares. The company reported ...

Shares of Resmed Inc. (RMD) traded over 7% higher in pre-market on Thursday morning after the company’s third-quarter ...

ResMed has a minority stake in Nyxoah who are developing a neurostimulation implant to treat OSA. Although we see little near-term risk from this therapy due to the higher cost and invasive surgery ...

Piper Sandler lowered the firm’s price target on ResMed (RMD) to $248 from $260 and keeps a Neutral rating on the shares. The firm notes the ...

ResMed dominates healthcare devices with innovation, recurring revenues, and market leadership. See why we believe RMD stock ...